Although renal cell carcinoma (RCC) is more commonly found in adults older than 60 years, recent data show a rising rate of aggressive RCC among US adults aged 20 to 39 years. Cancer stage migration ...
Limited data exist on outcomes in mRCC patients with major venous involvement (MVI). Assessment of impact of a given variable on prognosis in cancer patients is challenging given competing causes of ...
In patients with renal cell carcinoma, a phase 2 trial tested neoadjuvant stereotactic ablative radiation therapy to the inferior vena cava tumor thrombus before radical nephrectomy with thrombectomy.
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Phase I Study Combining Treatment With Temsirolimus and Sunitinib Malate in Patients With Advanced Renal Cell Carcinoma This phase I study evaluated temsirolimus in combination with sunitinib in ...
Select patients with oligometastatic ccRCC might be managed with a period of metastasis-directed therapy alone. Serial metastasis-directed radiation therapy may delay systemic therapy in clear cell ...
An international study examined outcomes between a single-port (SP) versus a multi-port (MP) approach to RAPN, with a focus on elderly patients. Despite similar demographics among patients ≤64 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback